Defender Capital LLC Investment Activity Analysis: Q2 2026 Portfolio Shifts
Defender Capital's portfolio saw significant changes in Q2 2026 with notable purchases and sales across various sectors, including Technology and Industrials.

Defender Capital, Llc. has released its investment activity report for the quarter ending June 30th, 2026, providing valuable insights into its portfolio adjustments during this period.
The investor's overall portfolio value stood at $307,742,153 as of the reporting date. Analysis reveals a dynamic approach to investing in Q2 2026, characterized by both strategic additions and disposals of significant holdings.
Prominent Purchases This Quarter
Defender Capital demonstrated substantial buying activity during this quarter, most notably adding shares to its largest position. The investor increased their stake in PALANTIR TECHNOLOGIES INC (PLTR) by 24,739 shares, representing a significant 8.68% weight increase to reach $16.46% of the total portfolio value.
This substantial allocation shift underscores Defender Capital's confidence in PLTR. Furthermore, the investor initiated new positions or significantly boosted small-cap holdings with purchases like ATOMERA INC (ATOM), where they acquired 295,450 shares entirely from scratch (change_percent_from_prior_period: 100.0%), adding $2,573,370 to the portfolio.
The investor also showed strong interest in other small-cap opportunities during Q2 2026. Acquisitions included CELSIUS HOLDINGS INC (CELH) with a full quarter's worth of new shares purchased, and the addition of another small position in AMAZON.COM INC (AMZN), which saw its portfolio allocation jump to 2.22%.
Strategic Sales and Portfolio Realignment
Conversely, Defender Capital also made significant reductions in certain holdings during Q2 2026. The most pronounced exit was from STAAR SURGICAL CO (STAA), where the investor sold a substantial portion of their stake, reducing shares by over 33% (-213,355 shares) and lowering its portfolio percentage allocation from an unknown prior level down to 4.02%. This sale resulted in a nearly $12M reduction in value for this holding.
Other notable disposals include the significant reduction of ARM HLDGS (ARM), where shares decreased by 78,359 (-79.2%), though its portfolio allocation remained at a small 2.37%. The investor also trimmed their position in INTEL CORP (INTC), reducing shares by 7,900 (-79.0%), which slightly decreased its portfolio allocation to a negligible 1.22%.
These actions resulted in notable shifts within the portfolio's sector allocations for Q2 2026. Technology holdings saw their value increase significantly from $45M (prior) to $67M, now representing 21.92% of the total portfolio. Healthcare allocation also grew substantially, increasing by nearly $3M in value and reaching a new high of 17.48%. Financial Services maintained its largest sector allocation at 16.73%, while Consumer Defensive saw a slight dip to 10.0%.
Defender Capital's Q2 2026 activity highlights their focus on major Technology names like PLTR and BRK-B, alongside opportunistic small-cap buys such as ATOM and CELH. Their selling activities, particularly the large reduction in STAA and ARM, suggest a strategic rebalancing or unwinding of positions that may have been less aligned with current investment thesis.